Also, VCAM-1 and ICAM-1 were shown to be associated with the development of new post-acute myocardial infarction HF symptoms (Lino et al., 2019) and increased subset-specific monocyte expression of their receptors were observed in AHF patients, with potential prognostic value of VCAM-1R (Wrigley et al., 2013) and sVCAM-1 after ST-elevation myocardial infarction (Hayek et al., 2021). Here, VCAM1 is linked to myocardial infarction.